The CRISPR Patent Landscape: Past, Present, and Future.

Area of Science:

• Biotechnology
• Intellectual Property Law
• Genomic Research

Background:

• The CRISPR patent landscape's origins predate its application as a gene editing technology.
• Fundamental patents for CRISPR-Cas9 gene editing emerged in 2012, initiating a significant legal dispute.
• Despite ongoing litigation, widespread licensing has fueled extensive research.

Purpose of the Study:

• To analyze the historical development of CRISPR patents.
• To examine the present state of CRISPR patent disputes and licensing.
• To assess the future implications of CRISPR technology on patentability and institutional responses.

Main Methods:

• Review of historical patent filings and legal documents.
• Analysis of licensing agreements and research output.
• Examination of patent law principles, including obviousness.

Main Results:

• CRISPR patent disputes, notably between the University of California and the Broad Institute, have shaped the field.
• Widespread licensing has facilitated a surge in academic and commercial CRISPR research.
• The ease and reliability of CRISPR may challenge the validity of future patents.

Conclusions:

• The future accessibility of CRISPR technology is uncertain and contingent on ongoing patent disputes.
• The "obviousness" of CRISPR applications poses a threat to future patentability.
• Researchers and academic institutions play a crucial role in navigating the future CRISPR patent landscape.